Together with the SMR award lecture the "Recent Disclosures of Clinical Candidates” meeting features an excellent array of novel molecular therapeutics across several target classes and therapeutic areas, which include oncology (inhibitors of BTK and Mdm2), pain (Nav1.7 modulation), CNS (highly selective M1 agonists and BACE1 inhibitors), bacterial infection (inhibitors of Clostridium difficile) and allergic inflammation (intranasal TLR7 agonists).
Recent Disclosures of Clinical Candidates and SMR Award Lecture
4 December 2014, London, United Kingdom
Introduction
Venue
National Heart and Lung Institute
Lecture Theatre, National Heart and Lung Institute, Dovehouse Street, Kensington, London, SW3 6LY, United Kingdom
Useful links
Organised by
Society for Medicines Research
Contact information
Related events
New Zealand Institute of 91AV Conference 2024 (NZIC-24)
24 November 2024 14:00 - 28 November 2024 14:00, Dunedin, New Zealand
Future Labs Live Basel
27 May 2025 09:00 - 28 May 2025 17:00, Basel, Switzerland
ADMET 2025
26 February 2025 10:00-17:00, London, United Kingdom
What a chemist needs to know about biology 1: In vitro biology
25 February 2025 10:00-17:00, London, United Kingdom
Search
Advertisement
Spotlight
Explore
Membership
